Triochem Products

What Triochem Products does

Triochem Products Limited is a Mumbai-headquartered, publicly listed (BSE: 512101) Indian pharmaceutical manufacturer and exporter established in 1972. The company produces pharmaceutical bulk drugs, Active Pharmaceutical Ingredients (APIs), and specialty chemicals including iodine compounds, citrate salts, piperazine salts, and organic/inorganic chemicals. All products are manufactured at a single facility in Ambernath (Thane district, Maharashtra) and tested in an in-house quality control laboratory to ensure compliance with international pharmacopoeia standards: British Pharmacopoeia (BP), United States Pharmacopoeia (USP), European Pharmacopoeia (EP), Indian Pharmacopoeia (IP), and Food Chemicals Codex (FCC).

The company's business model centers on direct B2B export sales of pharmaceutical ingredients to international drug manufacturers and pharmaceutical companies. It serves customers across 12+ countries spanning Europe (Germany, France, Netherlands, UK), the Americas (USA, Brazil, Mexico, Guatemala), and South East Asia (Korea, Indonesia, Taiwan, Australia). Revenue is generated through one-time product sales under quote-based pricing typical of B2B bulk pharmaceutical exports. The company emphasizes quality compliance, timely delivery, competitive pricing, customized products, and flexible packing as core value propositions. It is family-controlled, with the Deora family holding key leadership positions, and files Non-Applicability Certificates for Corporate Governance under SEBI (LODR) Regulations, reflecting its smaller public company status.

Triochem Products maintains a minimal physical footprint (one registered office in Mumbai and one manufacturing unit in Ambernath) and a lean corporate structure. The company has over four decades of international business experience and positions itself as a pioneer in pharmaceutical bulk drug manufacturing in India. Its go-to-market relies on direct customer engagement via dedicated export (exim@) and sales (sales@) email channels, with investor relations maintained as a key communication channel given its listed status.

Name

Triochem Products

Legal name

Triochem Products Limited

Website

https://triochemproducts.com

Company type

Public

Founded year

1972

Operating status

Operating

Headcount range

1–10 employees

Short description

Triochem Products Limited is a Mumbai-based, publicly listed Indian manufacturer and exporter of pharmaceutical bulk drugs, APIs, and specialty chemicals, serving international pharmaceutical companies across Europe, the Americas, and South East Asia since 1972.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

akta.pro secondary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

Keywords

• Pharmaceutical bulk drugs
• Active pharmaceutical ingredients
• Iodine compounds
• Citrate salts
• Piperazine derivatives

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Bulk Drugs and APIs Sales: Manufacture and export of pharmaceutical bulk drugs, Active Pharmaceutical Ingredients (APIs), and organic and inorganic chemicals. Revenue generated through product sales to international pharmaceutical companies across Europe, America, and South East Asia.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Triochem Products manufactures and exports pharmaceutical bulk drugs (APIs) and a range of organic and inorganic chemicals, including iodine compounds, citrates and piperazine salts, for use in pharmaceutical and industrial applications globally. The company operates its own manufacturing infrastructure and an in-house quality control laboratory, with operations built around a Build-Own-Operate-Transfer (BOOT) arrangement with Triochem Laboratories Limited.

Product overview

Triochem Products operates as a manufacturer and exporter of pharmaceutical bulk drugs, Active Pharmaceutical Ingredients (APIs), and specialty chemicals. The product portfolio centers on five core offerings: Pharmaceutical Bulk Drugs and APIs, Iodine Compounds, Citrates, Piperazine Salts, and Organic & Inorganic Chemicals. All products are manufactured in-house at their Ambernath facility and tested in their own laboratory to ensure compliance with International Standards including BP/USP/EP/IP/FCC. The company exports to Europe (Germany, France, Netherlands, UK), America (USA, Brazil, Mexico, Guatemala), and South East Asia (Korea, Indonesia, Taiwan, Australia).

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Bulk Drugs and APIs

Quantifiable outcome

• Products tested and released only after compliance with International Standards as well as Customer Requirements

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Aurobindo Pharma: One of India's largest API and generic finished-dose manufacturers, exporting globally. Comparable as an Indian-headquartered API exporter serving regulated markets, though at vastly greater scale and with a much broader therapeutic and chemical portfolio.
• Lupin: Major Indian pharmaceutical manufacturer with API operations and global generics exports. Comparable as an Indian-headquartered, export-oriented pharma company with API capabilities, though far larger and more diversified.
• Cipla: Major Indian pharmaceutical manufacturer with significant API operations and global exports. Comparable as an Indian-headquartered pharma exporter, though vastly larger and more diversified across dosage forms and therapeutic areas.
• Dr. Reddy's Laboratories: Large Indian pharmaceutical company with API manufacturing and global B2B exports. Comparable in being an Indian-listed pharma exporter, though at much greater scale, with proprietary products and complex generics.

Direct peers

• Divis Laboratories: Indian API and intermediates manufacturer with strong export orientation to regulated markets. Closely comparable as an India-based, export-led API producer, though Divis operates at materially larger scale and with deeper R&D investment.
• Granules India: Indian manufacturer and exporter of APIs, intermediates, and finished dosages with global B2B customers. Comparable as a publicly listed Indian API exporter serving regulated markets, though with a more vertically integrated and larger operation.
• Hikal Limited: Indian manufacturer of APIs, intermediates, and specialty chemicals serving global pharma and agrochemical customers. Comparable as a mid-sized Indian specialty chemical/API exporter with multi-pharmacopoeia capability.
• SMS Pharmaceuticals: Smaller-cap Indian API and intermediate manufacturer with global export footprint. Highly comparable in size, product mix (APIs/intermediates), and export-oriented B2B model to Triochem.
• Anuh Pharma: Indian API manufacturer focused on macrolide and specialty antibiotics, exporting globally. Comparable in scale and as an Indian API exporter serving regulated markets with multi-pharmacopoeia compliance.
• Bal Pharma: Small-cap Indian manufacturer of APIs, intermediates, and finished formulations with export orientation. Comparable in size and business model to Triochem as a niche Indian API and specialty chemical exporter.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/triochem-products-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Triochem Products